Evidence map›Paper›PMID 42118109›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2026

The subset of M1-paired MHC class II conformers is critical for CD4+ T cell activation.

Sophia Cangialosi, Jesse L Cimino, Safiehkhatoon Moshkani, Matthew J Kryzak, Michael D Robek, James R Drake

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Sophia CangialosiDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, United States.
Jesse L CiminoDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, United States.
Safiehkhatoon MoshkaniDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, United States.
Matthew J KryzakDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, United States.
Michael D RobekDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, United States.
James R DrakeDepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY, United States.

Funding

Human mechanisms of virus persistence in an AAV-based mouse model of chronic HBV infectionR01AI148354 · NIAID · ALBANY MEDICAL COLLEGE · PI ROBEK, MICHAEL · 2020 to 2024
$2.5M
Development of Conformer-Specific Anti-I-A Class II mAbsR03AI190276 · NIAID · ALBANY MEDICAL COLLEGE · PI DRAKE, JAMES R · 2025 to 2025
$164k
Development of Conformer-Specific Anti-HLA Class II mAbsR03AI165365 · NIAID · ALBANY MEDICAL COLLEGE · PI DRAKE, JAMES R · 2021 to 2022
$163k
Albany Medical College Institutional FundsNational Institute of Allergy and Infectious Diseases of the National Institutes of Health R01AI148354National Institute of Allergy and Infectious Diseases of the National Institutes of Health R03AI165365NIAID NIH HHS R01 AI148354NIAID NIH HHS R03 AI165365NIAID NIH HHS R03 AI190276NIH HHS
6 · The paper itself

Abstract

Major histocompatibility complex class II molecules present exogenous antigen-derived peptide to CD4+ T cells leading to T cell activation as well as signaling into the antigen-presenting cell. Class II is an αβ heterodimer that forms 2 distinct conformers via differential pairing of transmembrane domain GxxxG motifs (i.e. M1- and M2-paired class II). Previous studies with mouse I-Ak and human HLA-DR class II used conformer-specific monoclonal antibodies (mAbs) to define unique immunobiological properties of each conformer. Here, we report that AMS-32.1, a widely used anti-I-Ad mAb, is-specific for the 20% of M1-paired I-Ad class II expressed by the cell, and 34-5-3S anti-I-Ad mAb is non-conformer specific. While AMS-32.1 engagement of M1-paired I-Ad elicits B cell calcium signaling, 34-5-3S coengagement of M1 and M2-paired I-Ad blocks this response, indicating M2-paired class II inhibits M1-paired class II signaling. In vitro, AMS-32.1 blocks >90% of T cell activation by ovalbumin peptide-I-Ad complexes, even under conditions where peptide is loaded onto both conformers. In vivo, AMS-32.1 blocks accumulation of ovalbumin-specific CD4+ T cells in the spleen and lymph nodes. In a murine model of hepatitis B virus replication, in which major histocompatibility complex class II-restricted T cell-dependent humoral responses are key to antigen clearance, AMS-32.1 blocks hepatitis B surface antigen seroconversion, indicating that M1-paired class II is central to the in vivo development of CD4+ T cell-dependent antibody responses. Overall, this study reveals that AMS-32.1 is specific for M1-paired I-Ad class II and that M1-paired class II is critical for CD4+ T cell activation both in vitro and in vivo.

Indexed as

CD4-Positive T-LymphocytesHistocompatibility Antigens Class IILymphocyte ActivationAnimalsAntibodies, MonoclonalAntigen PresentationHumansMiceMice, Inbred C57BLAntibodies, MonoclonalHistocompatibility Antigens Class IIantigen processing/presentationB cellMHC class IIT cell

Identifiers

PMID42118109
PMCPMC13162909

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.